JP2023507561A5 - - Google Patents
Info
- Publication number
- JP2023507561A5 JP2023507561A5 JP2022535058A JP2022535058A JP2023507561A5 JP 2023507561 A5 JP2023507561 A5 JP 2023507561A5 JP 2022535058 A JP2022535058 A JP 2022535058A JP 2022535058 A JP2022535058 A JP 2022535058A JP 2023507561 A5 JP2023507561 A5 JP 2023507561A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- storage
- amino acid
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025175127A JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962946207P | 2019-12-10 | 2019-12-10 | |
| US62/946,207 | 2019-12-10 | ||
| PCT/US2020/064025 WO2021119135A1 (en) | 2019-12-10 | 2020-12-09 | Stabilized formulations containing anti-cd20 x anti-cd3 bispecific antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175127A Division JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023507561A JP2023507561A (ja) | 2023-02-24 |
| JP2023507561A5 true JP2023507561A5 (cg-RX-API-DMAC10.html) | 2023-12-18 |
| JP7813703B2 JP7813703B2 (ja) | 2026-02-13 |
Family
ID=74141846
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535058A Active JP7813703B2 (ja) | 2019-12-10 | 2020-12-09 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
| JP2025175127A Pending JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025175127A Pending JP2026016480A (ja) | 2019-12-10 | 2025-10-17 | 抗ｃｄ２０×抗ｃｄ３二重特異性抗体を含有する安定化製剤 |
Country Status (15)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202400228A (zh) | 2022-02-25 | 2024-01-01 | 美商再生元醫藥公司 | 減輕細胞激素釋放症候群的給藥方案 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0747045B2 (ja) | 1986-10-15 | 1995-05-24 | 株式会社大協精工 | 積層した注射器用滑栓 |
| JP3100727B2 (ja) | 1992-01-23 | 2000-10-23 | 株式会社大協精工 | 変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品 |
| JP3172057B2 (ja) | 1995-04-05 | 2001-06-04 | 株式会社大協精工 | ラミネートゴム栓 |
| JP3512349B2 (ja) | 1999-01-29 | 2004-03-29 | 株式会社大協精工 | 柱状ゴム要素の成形型 |
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| JP2002209975A (ja) | 2001-01-19 | 2002-07-30 | Daikyo Seiko Ltd | 医薬バイアル用ラミネートゴム栓 |
| ES2537738T3 (es) * | 2003-06-05 | 2015-06-11 | Genentech, Inc. | Terapia de combinación para trastornos de células B |
| EP2225275A4 (en) * | 2007-11-28 | 2013-04-03 | Medimmune Llc | PROTEIN FORMULATION |
| JP2012041317A (ja) * | 2010-08-23 | 2012-03-01 | Panasonic Corp | フェロセン修飾抗体 |
| WO2012135408A1 (en) * | 2011-03-31 | 2012-10-04 | Merck Sharp & Dohme Corp. | Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments |
| JOP20200236A1 (ar) | 2012-09-21 | 2017-06-16 | Regeneron Pharma | الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها |
| HUE050159T2 (hu) * | 2013-12-17 | 2020-11-30 | Genentech Inc | Anti-CD3 antitestek és alkalmazási eljárások |
| ES2809455T3 (es) * | 2014-11-17 | 2021-03-04 | Regeneron Pharma | Métodos para tratamiento tumoral usando anticuerpo biespecífico CD3xCD20 |
| CN108602889A (zh) * | 2015-12-22 | 2018-09-28 | 瑞泽恩制药公司 | 医治急性成淋巴细胞性白血病的双特异性抗cd20/抗cd3抗体 |
| TWI865430B (zh) * | 2017-07-24 | 2024-12-11 | 美商再生元醫藥公司 | 穩定化之抗體組合物及其製法 |
| MA49960A (fr) * | 2017-08-25 | 2021-06-02 | Omeros Corp | Formulations d'anticorps inhibiteurs de masp-2 hautement concentrées à faible viscosité, kits et méthodes de traitement de sujets souffrant d'un syndrome hémolytique atypique |
| CA3202891A1 (en) * | 2021-01-28 | 2022-08-04 | Kara Olson | Compositions and methods for treating cytokine release syndrome |
-
2020
- 2020-12-08 TW TW109143208A patent/TW202135860A/zh unknown
- 2020-12-09 CN CN202080092885.6A patent/CN115003331A/zh active Pending
- 2020-12-09 JP JP2022535058A patent/JP7813703B2/ja active Active
- 2020-12-09 CA CA3161059A patent/CA3161059A1/en active Pending
- 2020-12-09 WO PCT/US2020/064025 patent/WO2021119135A1/en not_active Ceased
- 2020-12-09 KR KR1020227021715A patent/KR20220113417A/ko active Pending
- 2020-12-09 PH PH1/2022/551275A patent/PH12022551275A1/en unknown
- 2020-12-09 BR BR112022011150A patent/BR112022011150A2/pt unknown
- 2020-12-09 MY MYPI2022003031A patent/MY210570A/en unknown
- 2020-12-09 AU AU2020402030A patent/AU2020402030A1/en active Pending
- 2020-12-09 IL IL293372A patent/IL293372A/en unknown
- 2020-12-09 EP EP20838711.8A patent/EP4072585A1/en active Pending
- 2020-12-09 US US17/116,699 patent/US20210206870A1/en not_active Abandoned
-
2022
- 2022-06-07 CL CL2022001495A patent/CL2022001495A1/es unknown
- 2022-06-22 CO CONC2022/0008684A patent/CO2022008684A2/es unknown
-
2024
- 2024-05-22 CL CL2024001536A patent/CL2024001536A1/es unknown
- 2024-11-11 CL CL2024003444A patent/CL2024003444A1/es unknown
-
2025
- 2025-04-07 US US19/171,676 patent/US20250236677A1/en active Pending
- 2025-10-17 JP JP2025175127A patent/JP2026016480A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7440464B2 (ja) | 抗アクチビンａ抗体及びその使用 | |
| AU2020201219B2 (en) | Methods of treating or preventing cholesterol related disorders | |
| RU2363706C2 (ru) | Антитела к рецептору инсулиноподобного фактора роста i и их применение | |
| AU2021202839A1 (en) | Human antibodies to ebola virus glycoprotein | |
| FI3606504T3 (fi) | Stabiili vasta-aineformulaatio | |
| RU2017107847A (ru) | Стабильный состав на основе антитела к il-4r-альфа | |
| JP2021515566A5 (cg-RX-API-DMAC10.html) | ||
| JP2023011710A (ja) | Ｓ．ａｕｒｅｕｓ溶血素ａ毒素に対するヒト抗体 | |
| JP2020518600A5 (cg-RX-API-DMAC10.html) | ||
| JP2009507838A (ja) | 抗ｃｄ３抗体製剤 | |
| JP2020518598A5 (cg-RX-API-DMAC10.html) | ||
| FI3773738T3 (fi) | Vasta-aine-lääkekonjugaatteja ja niiden käyttöjä syövän hoitamiseksi | |
| JP2023545183A5 (cg-RX-API-DMAC10.html) | ||
| KR20220140772A (ko) | 인간 항-tslp 항체 제형 및 염증성 질환의 치료 방법 | |
| JP2025502061A5 (cg-RX-API-DMAC10.html) | ||
| JP2026016480A5 (cg-RX-API-DMAC10.html) | ||
| JP2024513835A5 (cg-RX-API-DMAC10.html) | ||
| CN114685653B (zh) | 抗新冠病毒受体结合区域表位中和抗体及其应用 | |
| RU2745814C1 (ru) | Водная фармацевтическая композиция левилимаба и ее применение | |
| KR20240100493A (ko) | 항-cd22 항체의 수성 제제 및 이의 용도 | |
| AU2022246842A9 (en) | Multispecific binding moieties comprising novel pd-1 binding domains | |
| JP2024502670A5 (cg-RX-API-DMAC10.html) | ||
| RU2024122332A (ru) | СПОСОБЫ ЛЕЧЕНИЯ РЕЦИДИВИРУЮЩЕГО РАКА ЯИЧНИКА С ПОМОЩЬЮ БИСПЕЦИФИЧНЫХ АНТИТЕЛ К MUC16 x CD3 ОТДЕЛЬНО ИЛИ В КОМБИНАЦИИ С АНТИТЕЛАМИ К PD-1 | |
| RU2026105218A (ru) | Способы лечения светлоклеточного рака почек с помощью биспецифических антител к psma/cd28 | |
| JP2021518393A5 (cg-RX-API-DMAC10.html) |